The term of superficial

or invasive bladder tumor is confusing as it implies that only one kind of superficial or invasive bladder cancer exists[3]. Understanding the molecular biology of bladder cancer and Savolitinib price metastasis may provide insight for the development of novel tumor markers or new therapeutic strategies. Epithelial-mesenchymal transition (EMT) has emerged as a critical process during cancer progression in which downregulation or loss of E-cadherin expression (epithelial marker) constitute a molecular hallmark [4, 5]. The transcriptional factors Snail and Slug (zinc finger proteins) have been described to be direct repressors of E-cadherin [6–11]in vitro and in vivo through an interaction of their COOH-terminal region with a 5′-CACCTG-3′ sequence in the E-cadherin promoter [12]. Both have been suggested to be involved in the acquisition of resistance VX-689 ic50 to apoptosis, thereby promoting tumor survival. Recently, check details it has been postulated that

Twist, another promoter repressor of CDH1 (E-cadherin gene), may be involved in tumor progression by silencing E-cadherin expression and EMT induction [13, 14]. Twist is considered as a promoter of the EMT, which is a key event in the tumoral invasion step. Up-regulation of Twist is associated with malignant transformation of melanoma and T-cell lymphoma [13]. It is possibly involved in E-cadherin conversion during EMT [14]. Studies in other cancers have shown that overexpression of Snail and Slug leads to a reduction of E-cadherin expression. An overexpression of Twist resulted in an a further decrease of E-cadherin expression [15]. Because Snail, Twist and Slug

are potential regulators of cell adhesion and migration, this study aimed to determine the levels of expression of Snail, Slug, and Twist in human bladdert cancer tissues and to elucidate whether these levels are clinically significant. Also, to clarify whether the three factors may be used as a novel parameter to predict prognosis mafosfamide in bladder carcinoma. Materials and methods Patients and paraffin-embedded tissue sample The study included 120 patients with a primary bladder tumor and 42 background tissue(paracarcinoma tissue, more than 1.5-2 cm from cancer tissue). The tissues were obtained from patients who had undergone a transurethral resection or a partial/total cystectomy between 1999 and 2002 at the Urology Department, The affiliated hospital of Qingdao medical college, Qingdao university, China. None of the patients had received preoperative treatment. All patients were classified according to the 1997 UICC TNM classification for the stage and OMS 2004 for the grade (LMP: low malignant potential; LG: low grade; HG: high grade). Immunostaining was evaluated by 2 independent pathologists to validate the diagnosis. Each sample was used after written consent was obtained from the patients.